tapebrief
Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.

BG · Q1 2026 Earnings

Bunge Global

Reported April 29, 2026

30-second summary

30-second take: Bunge delivered Q1 adjusted EPS of $1.83 — roughly double the $0.80–$0.95 range implied by management's own "lightest quarter in a long time" framing three months ago — and raised FY2026 adjusted EPS guidance to $9.00–$9.50 from $7.50–$8.00, a $1.25 midpoint lift (+16.7%). Soybean and Softseed Processing are doing the work; Tropical Oils and Grain Merchandising are now guided lower, and net interest expense was quietly raised again to $620–$660M. The cycle-bottom narrative that dominated the last two prints has been retired in one quarter.

Headline numbers

EPS

Q1 FY2026

$1.83

Revenue

Q1 FY2026

$21.86B

+87.8% YoY

Gross margin

Q1 FY2026

3.5%

Operating margin

Q1 FY2026

0.8%

Key financials

Q1 FY2026
MetricQ1 FY2026YoYQ4 FY2025QoQ
Revenue$21.86B+87.8%$23.76B-8.0%
EPS$1.83$1.99-8.0%
Gross margin3.5%4.3%-76bps
Operating margin0.8%1.1%-27bps

Guidance

Bunge raised full-year 2026 adjusted EPS guidance by 16.7% to $9.00–$9.50 from $7.50–$8.00, driven by strong Soybean and Softseed Processing, though net interest expense was also increased.

Guidance is issued for both next quarter and the full year. Both may appear below.

Changes to prior guidance

MetricPeriodPrior guideNew guideΔResult
Adjusted EPS
FY 2026
$7.50 to $8.00$9.00 to $9.50+$1.50 to $1.50 (midpoint +$1.25, or +16.7% raise)Raised
Adjusted annual effective tax rate
FY 2026
23% to 27%22% to 26%-100 bps on both low and high endLowered
Net interest expense
FY 2026
$575 to $625 million$620 to $660 million+$45M to $35M (midpoint +$40M, or +6.5% raise)Raised

Reaffirmed unchanged this quarter: Capital expenditures ($1.5 to $1.7 billion), Depreciation and amortization (approximately $975 million)

Segment performance

Q1 FY2026
SegmentQ1 FY2026YoY
Soybean Processing and Refining$9.552B+43.4%
Softseed Processing and Refining$3.904B+157.6%
Tropical Oils and Specialty Ingredients$1.228B+13.4%
Grain Merchandising and Milling$7.177B+201.1%

Platform metrics

Q1 FY2026
SegmentQ1 FY2026
Soybean Processing Volume10,757 thousand metric tons
Softseed Processing Volume3,281 thousand metric tons
Grain Merchandising Volume26,558 thousand metric tons
Full-Year 2026 Adjusted EPS Guidance$9.00 to $9.50
Refined Soy Oil Production857 thousand metric tons

Profitability

Q1 FY2026
SegmentQ1 FY2026
Adjusted Total EBIT$561 million
Adjusted Segment EBIT$661 million
Adjusted FFO$530 million

Management tone

Cycle bottom → Viterra dilution acknowledged → cautious cycle bottom → tangible margin recovery with disciplined hedging. The four-quarter arc has inflected. Three quarters ago Bunge was describing 2026 as a structurally back-half year with Q1 the lightest "in a long time"; this quarter Q1 came in at $1.83 and management raised the FY guide 16.7% — but the language remained heavily hedged. "based on what we can see today," "forward curves in certain regions have reacted, but significant uncertainty remains," "we'll wait and see new crop" — the verbal posture is bullish in actions, defensive in words.

The H1/H2 mix shifted materially. Last quarter management telegraphed a 30/70 H1/H2 split with a 35/65 Q1/Q2 inside H1; this quarter the new framing is "40% first half, 60% second half. And then when we look at the second half, it's a little more even, but we're looking at 45, 55, Q3, Q4." The earnings curve flattened — H1 is materially stronger than expected, and H2 is no longer the make-or-break it was framed as in February. The Q4 hockey stick is no longer the load-bearing assumption.

Viterra synergies moved from "really contributing more as we get into 27" to ahead-of-plan execution. Management said "VITERA cost synergies are running ahead of plan, and we've identified significant network and commercial opportunities." This is the first quarter in four where the Viterra integration narrative carries net positive momentum rather than a deferral cadence. Whether the March Investor Day delivered a quantified synergy number isn't visible in this print, but the qualitative tone shift is real: integration risk is fading, and management is starting to signal optionality rather than excuse-making.

The forward-visibility framing remains genuinely cautious in a way that doesn't match the guide raise. "You don't have the farmers engaging out forward. You also don't have the end consumer engaging out forward...there is a little bit lack of liquidity going forward." Bunge raised FY EPS 16.7% while telling analysts that customers across both ends of the value chain are spot-only. The honest read: management has visibility into Q1-Q2 hedges that are already locked, and they're guiding the year off that base — the H2 of the raise is leverage to spot dynamics they explicitly say they cannot see.

The RMI assumption shift from 50% to 70% in leverage calculations is a quiet but important rerating mechanic. Higher RMI credit means lower reported net leverage on the same balance sheet, which gives management more headroom for capital return without a credit narrative change. It's the kind of change that doesn't make headlines but materially reframes capital allocation flexibility going into the second half.

Recurring themes management leaned on this quarter:

Middle East supply chain disruption driving higher logistics and energy costsRenewable diesel/biodiesel tailwind from RVO clarity and fuel security concernsVITERA synergies running ahead of plan with expanded origination and processing footprintSoybean and soft seed processing strength offsetting grain merchandising weaknessInverted forward curves limiting visibility into second-half demandGlobal uncertainty around geopolitics, El Niño risk, and crop development

Risks management surfaced:

Uncertain duration of Middle East conflict and ongoing supply chain disruptionInverted forward curves and lack of liquidity in commodity markets reducing forward visibilityPotential El Niño development affecting crop outcomes and farmer planting decisionsEuropean soft seed crop weakness (two consecutive years) creating margin pressure until new cropChina-U.S. trade dynamics and tariff uncertainty affecting customer buying patterns

Answers to last quarter's watch list

Q1 2026 adjusted EPS print vs. the implied $0.80–$0.95 range — Q1 adjusted EPS came in at $1.83, roughly double the high end of the range implied by management's own H1 split commentary. This is a decisive rejection of the "lightest quarter in a long time" framing. The earnings curve has flattened to 40/60 H1/H2 from 30/70, meaning Bunge front-ran its own conservative setup.
Resolved positively
March 2026 Investor Day Viterra synergy quantification — Not directly addressed in this press release. Management said cost synergies are "running ahead of plan" with "significant network and commercial opportunities" identified, but the Q1 release does not appear to publish a dollar synergy target with a 2027 calendar. The qualitative posture improved meaningfully; whether the Investor Day delivered the quantified number requires the transcript.
Continue monitoring
Whether the FY2026 EPS guide gets refreshed at Q1 — Raised to $9.00–$9.50 from $7.50–$8.00, a $1.25 midpoint lift (+16.7%). This is the most aggressive single-quarter guidance raise Bunge has issued in the Viterra era and definitively answers that spot margins are tracking well ahead of the curve-derived placeholder.
Resolved positively
US RVO finalization and R&SO/biofuel demand — Management cited "renewable diesel/biodiesel tailwind from RVO clarity and fuel security concerns" as a contributor, suggesting policy direction has firmed up enough to incorporate into the model. The Tropical Oils and Specialty Ingredients segment is now guided lower, however, which complicates the clean-RVO-upside narrative — the biofuel benefit appears to be flowing more through Processing than R&SO/Tropical Oils. Status: Resolved positively (with mix-shift caveat).
Net interest expense actuals vs. $575–$625M guide — Raised to $620–$660M, a $40M midpoint increase (+6.5%). Q1 actuals aren't broken out in the available detail, but the upward revision suggests the prior guide was already too low, consistent with the watch item's threshold. This is the third consecutive quarter the post-Viterra interest run-rate has been revised upward.
Resolved negatively
Commercial synergy disclosure from Viterra — Management explicitly called out "significant network and commercial opportunities" identified beyond cost synergies — the first quarter in the Viterra era where commercial (revenue) synergies are mentioned distinctly from cost synergies. No dollar quantification yet, but the line in the prepared comments is a meaningful narrative upgrade.
Continue monitoring

What to watch into next quarter

Q2 2026 adjusted EPS print — under the new 40/60 H1/H2 framework, with $9.25 FY midpoint, H1 is ~$3.70 and Q2 is implied near $1.85–$1.90. A print below $1.70 would suggest Q1 pulled forward H2 earnings; a print above $2.00 means another guide raise is coming at Q2

Whether Tropical Oils and Grain Merchandising actually deliver the "lower" outcomes management is signaling, or whether those guides have been set up as the next conservative buffer to manage

Net interest expense Q1 actual annualized run-rate — if it exceeds $660M annualized, FY guide will be revised up a fourth time

Whether the Q2 release quantifies Viterra commercial synergies in dollars, validating the "significant network and commercial opportunities" language with a number

Soybean crush margin curves for H2 2026 and 2027 — with management explicitly noting forward curves "have reacted" but liquidity is thin, any disclosure of forward hedge coverage would reset the durability debate on the $9.25 midpoint

El Niño development and its impact on South American new crop — management flagged this as the cleanest tail risk to the back-half setup

Sources

  1. Bunge Global Q1 2026 earnings press release (SEC EDGAR, filed April 29, 2026): https://www.sec.gov/Archives/edgar/data/1996862/000162828026028079/epr03312026.htm
  2. Bunge Global Q4 2025 / FY2025 earnings press release (prior-period guide baseline): https://www.sec.gov/Archives/edgar/data/1996862/000162828026005261/epr123120254.htm

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.